1. Home >
  2. M&A >
  3. Merger >
  4. United States >
  5. Massachusetts >
  6. VBI Vaccines Acquires VBI Vaccines

M&A Deal Summary

VBI Vaccines Acquires VBI Vaccines

On October 26, 2015, VBI Vaccines acquired life science company VBI Vaccines

Acquisition Highlights
  • This is VBI Vaccines’ 1st transaction in the Life Science sector.
  • This is VBI Vaccines’ 1st transaction in the United States.
  • This is VBI Vaccines’ 1st transaction in Massachusetts.

M&A Deal Summary
Date 2015-10-26
Target VBI Vaccines
Sector Life Science
Buyer(s) VBI Vaccines
Deal Type Merger
Advisor(s) Mitchell Silberberg & Knupp (MSK)
Borden Ladner Gervais (BLG)
Yehuda Raveh & Co. (Legal)

Target

VBI Vaccines

Cambridge, Massachusetts, United States
VBI Vaccines is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI Vaccines is based in Cambridge, Massachusetts.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

VBI Vaccines

Cambridge, Massachusetts, United States
Category Company
Founded 2005
Sector Life Science
Employees127
Revenue 3M USD (2014)
DESCRIPTION

VBI Vaccines is a biopharmaceutical company focused on the development and commercialization of novel and improved therapies for the prevention and treatment of hepatitis B and Graft-vs-Host Disease (GVHD) using our proprietary recombinant protein expertise. VBI Vaccines was founded in 2005 and is based in Cambridge, Massachusetts.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Merger M&A Deals 1 of 1
State: Massachusetts M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2015 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal